| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9271935 | Osteoarthritis and Cartilage | 2005 | 7 Pages |
Abstract
This analysis provides evidence for the capacity of OARSI and OMERACT-OARSI responder criteria to detect clinically important statistically detectable differences between treatment groups.
Keywords
NSAIDSACRWOMACOMERACTOARSIRandomized controlled trialEffectivenessOsteoarthritisOsteoarthritis Research Society Internationalstandard deviationNonsteroidal anti-inflammatory drugsWestern Ontario and McMaster Universities Osteoarthritis IndexHylan G-F 20normalized unitsAmerican College of Rheumatology
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Nicholas M.D., Mary J. M.D., Charlie H. Ph.D., Dan M.Math., Valery M.Sc., Jean-Pierre M.D., George W. Ph.D., Peter M.D., Richard M.D.,
